{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.371","value":"68.91"},{"groupId":"OG001","spread":"18.762","value":"68.04"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"238"},{"groupId":"OG001","value":"245"}],"units":"Participants"}],"title":"Baseline (BL)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.029","value":"1.39"},{"groupId":"OG001","spread":"18.767","value":"0.40"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"205"},{"groupId":"OG001","value":"199"}],"units":"Participants"}],"title":"Change from BL at Cycle 3 Day 1 (C3D1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.218","value":"2.60"},{"groupId":"OG001","spread":"23.294","value":"2.08"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"163"},{"groupId":"OG001","value":"157"}],"units":"Participants"}],"title":"Change from BL at C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.528","value":"5.28"},{"groupId":"OG001","spread":"20.805","value":"2.55"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"117"}],"units":"Participants"}],"title":"Change from BL at C9D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.380","value":"5.55"},{"groupId":"OG001","spread":"22.728","value":"1.18"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"93"},{"groupId":"OG001","value":"88"}],"units":"Participants"}],"title":"Change from BL at C12D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.940","value":"2.87"},{"groupId":"OG001","spread":"21.564","value":"3.72"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"84"},{"groupId":"OG001","value":"61"}],"units":"Participants"}],"title":"Change from BL at C15D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.474","value":"3.80"},{"groupId":"OG001","spread":"19.369","value":"6.87"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"53"}],"units":"Participants"}],"title":"Change from BL at C18D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.541","value":"3.70"},{"groupId":"OG001","spread":"18.577","value":"5.71"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Change from BL at C21D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.288","value":"1.73"},{"groupId":"OG001","spread":"18.781","value":"7.68"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"title":"Change from BL at C24D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.139","value":"-0.44"},{"groupId":"OG001","spread":"19.792","value":"4.63"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"35"}],"units":"Participants"}],"title":"Change from BL at C27D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.829","value":"3.13"},{"groupId":"OG001","spread":"14.998","value":"4.76"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"25"}],"units":"Participants"}],"title":"Change from BL at C30D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.923","value":"5.41"},{"groupId":"OG001","spread":"17.705","value":"1.64"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"22"}],"units":"Participants"}],"title":"Change from BL at C33D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.714","value":"-1.50"},{"groupId":"OG001","spread":"29.617","value":"-2.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Change from BL at C36D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"28.281","value":"3.57"},{"groupId":"OG001","spread":"20.078","value":"1.70"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Change from BL at C39D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.469","value":"-11.89"},{"groupId":"OG001","spread":"26.550","value":"-0.75"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Change from BL at C42D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.113","value":"2.00"},{"groupId":"OG001","spread":"24.042","value":"-2.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Change from BL at C45D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.000","value":"7.00"},{"groupId":"OG001","spread":"34.648","value":"5.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Change from BL at C48D1"}],"denoms":[{"counts":[{"groupId":"OG000","value":"238"},{"groupId":"OG001","value":"245"}],"units":"Participants"}],"description":"The EQ-5D-5L VAS records the participant's self-rated health on a visual analogue scale numbered from 0 to 100, with 0 being \"the worst health you can imagine\" and 100 being \"the best health you can imagine\". Change from baseline was presented.","dispersionType":"Standard Deviation","groups":[{"description":"Participants were randomized to sabatolimab plus Azacitidine","id":"OG000","title":"Sabatolimab (MBG453) + Azacitidine"},{"description":"Participants were randomized to placebo plus Azacitidine","id":"OG001","title":"Placebo + Azacitidine"}],"paramType":"MEAN","populationDescription":"FAS population with non-missing baseline EQ-5D-5L assessments. For each post-baseline timepoint, FAS population with non-missing baseline and post-baseline EQ-5D-5L assessment. FAS comprised of all patients to whom study treatment had been assigned by randomization.","reportingStatus":"POSTED","timeFrame":"Baseline, every 3 cycles up to C48D1 (1 cycle = 28 days)","title":"Change From Baseline in the European Quality of Life (EuroQoL) - 5 Dimensions, 5 Level Questionnaire (EQ-5D-5L) Visual Analogue Scale (VAS) Over Time","type":"SECONDARY","unitOfMeasure":"Scores on a scale"}